ES2192165T3 - Metodo para preparar cristales en forma ii de claritromicina de la forma ii. - Google Patents

Metodo para preparar cristales en forma ii de claritromicina de la forma ii.

Info

Publication number
ES2192165T3
ES2192165T3 ES00122798T ES00122798T ES2192165T3 ES 2192165 T3 ES2192165 T3 ES 2192165T3 ES 00122798 T ES00122798 T ES 00122798T ES 00122798 T ES00122798 T ES 00122798T ES 2192165 T3 ES2192165 T3 ES 2192165T3
Authority
ES
Spain
Prior art keywords
clarithromycin
claritromycin
preparing crystals
formate
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00122798T
Other languages
English (en)
Inventor
Kwee-Hyun Suh
Mi-Ra Seong
Nam-Du Kim
Gwan-Sun Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Original Assignee
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharmaceutical Co Ltd, Hanmi Pharmaceutical Industries Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2192165T3 publication Critical patent/ES2192165T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un método para preparar cristales en Forma II de claritromicina de fórmula (I), que comprende las etapas de: (a) tratar claritromicina con ácido fórmico en un disolvente orgánico para dar formiato de claritromicina cristalino de fórmula II y (b) neutralizar el formiato de claritromicina con una base en una mezcla de agua y un disolvente orgánico miscible con agua:
ES00122798T 1999-10-21 2000-10-19 Metodo para preparar cristales en forma ii de claritromicina de la forma ii. Expired - Lifetime ES2192165T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019990045703A KR100322313B1 (ko) 1999-10-21 1999-10-21 클라리스로마이신 결정형 2의 제조방법 및 이에 사용되는 클라리스로마이신 포르메이트

Publications (1)

Publication Number Publication Date
ES2192165T3 true ES2192165T3 (es) 2003-10-01

Family

ID=19616246

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00122798T Expired - Lifetime ES2192165T3 (es) 1999-10-21 2000-10-19 Metodo para preparar cristales en forma ii de claritromicina de la forma ii.

Country Status (7)

Country Link
US (1) US6444796B1 (es)
EP (1) EP1097938B1 (es)
JP (1) JP2001122890A (es)
KR (1) KR100322313B1 (es)
AT (1) ATE232211T1 (es)
DE (1) DE60001346T2 (es)
ES (1) ES2192165T3 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
KR20030047873A (ko) * 2000-02-29 2003-06-18 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 및 클라리트로마이신 중간체의 제조방법, 실질적으로는 옥심이 제거된 클라리트로마이신 및이를 포함하는 약학적 조성물
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
AU2004270170B2 (en) * 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US20060111560A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Process for the preparation of crystalline form II of clarithromycin
JP2009500356A (ja) * 2005-07-07 2009-01-08 エラン ファーマ インターナショナル リミテッド ナノ粒子クラリスロマイシン製剤
WO2007036951A2 (en) * 2005-08-31 2007-04-05 Alembic Limited Process to obtain 6-o-methylerythromycin a (clarithromycin)_form ii
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
EP2030613A1 (en) 2007-08-17 2009-03-04 Abbott GmbH & Co. KG Preparation of compositions with essentially noncrystalline embedded macrolide antibiotics
US20210313015A1 (en) * 2018-08-21 2021-10-07 Towa Pharmaceutical Co., Ltd. Specifically-shaped crystal of compound and method for producing same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
DE69730138T2 (de) * 1996-07-29 2005-03-03 Abbott Laboratories, Abbott Park Herstellung von kristallinen form ii von clarithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
US5945405A (en) * 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin

Also Published As

Publication number Publication date
KR100322313B1 (ko) 2002-02-06
EP1097938A1 (en) 2001-05-09
ATE232211T1 (de) 2003-02-15
DE60001346D1 (de) 2003-03-13
KR20010037942A (ko) 2001-05-15
US6444796B1 (en) 2002-09-03
DE60001346T2 (de) 2004-04-08
EP1097938B1 (en) 2003-02-05
JP2001122890A (ja) 2001-05-08

Similar Documents

Publication Publication Date Title
ES2192165T3 (es) Metodo para preparar cristales en forma ii de claritromicina de la forma ii.
AR079399A2 (es) Procedimientos para preparar bifenazato
CO5040054A1 (es) Metodo para preparar y purificar un derivado de aspartame n-alquilatado
BR0005872B1 (pt) sistema de agente de impermeabilização, seu emprego, processo para a impermeabilização de substratos, bem como substratos assim obtidos.
GT199900056A (es) Nuevas dihidropirimidinas
PE20001333A1 (es) Proceso para estabilizar macrolidos de polieno
ES2005572A6 (es) Un procedimiento para la preparacion de nuevos derivados del tetrahidronaftaleno
BRPI0516735B8 (pt) métodos para produção de (r)-2-acetamido-n-benzil-3-metoxipropionamida (lacosamida) e de uma formulação farmacêutica, e uso de (r)-n-benzil-2-nboc-amino-3-metoxipropionamida (c-937)
AR023129A1 (es) Composiciones para mejorar la fertilidad
TR200201146T2 (tr) Sertralin hidrokorid polimorfik formları.
ES2154626T1 (es) Sistema de regeneracion para vides y uso del mismo.
ECSP093680A (es) Proceso para derivados del acido fenilacetico
ATE235147T1 (de) Verfahren zum dehydratisieren von biologischen geweben zur herstellung von transplantat- konserven
EA201070228A1 (ru) Тразодон и гидрохлорид тразодона в очищенной форме
ATE341559T1 (de) Verfahren zur herstellung von clarithromycin
ES2117349T3 (es) Procedimiento para la purificacion de acido (met)acrilico en bruto.
AR046065A1 (es) Cristales de penam y procedimiento para la produccion de los mismos
NO20011046D0 (no) Ernæringsmessig mikroemulsjon i sprayform som er anvendelig som akselerator for bionedbrytning
AR048040A1 (es) Metodo de purificacion de mesotriona
AR041954A1 (es) Un proceso para preparar acetato de risperidona y compuestos intermediarios para dicho proceso
BRPI0017522B8 (pt) processo para preparação de secretagogos de hormônio de crescimento e polimorfo
BR0312604A (pt) ácidos imido-alcanpercarboxìlicos, composições, e, processo para a preparação e uso de ácidos imido-alcanpercarboxìlicos
BRPI0416535A (pt) processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo
BR0013751B1 (pt) processo para produÇço de derivados de Ácido naftiridina-3-carboxÍlico.
AR036886A1 (es) Proceso para preparar un elemento en forma de gel y dispositivo para purificar el aire.